Issue 29
Get instant access to latest e-book

latest newsRead more...

11

Dec 2017

Prime Therapeutics Signs Outcomes-Based Contract with Novo Nordisk for Type 2 Diabetes Drug Victoza® (liraglutide)

As the rate of diabetes continues to escalate in the United States health care payers are looking for solutions to help manage the cost of treating this serious disease while helping to ensure quality health care for their members This has led Prime Therapeutics LLC…

11

Dec 2017

Roche lymphoma drug drives high remission rate, longer survival

An experimental Roche Holding AG drug added to standard therapy led to a far higher rate of remission and helped patients with an advanced aggressive blood cancer live significantly longer than the standard treatment alone according to data from a midstage trial released at a…

08

Dec 2017

Gilead Sciences and Kite to Acquire Cell Design Labs

Gilead Sciences Inc and its cell therapy subsidiary Kite announced today that they have entered into a definitive agreement under which they have agreed to acquire Cell Design Labs Inc gaining new technology platforms that will enhance research and development efforts in cellular therapy Under…

press releasesRead more...

11

Dec 2017

Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Yescarta™ (Axicabtagene Ciloleucel) in Patients With Refractory Large B-cell Lymphoma

Kite a Gilead Company announced longterm followup data from the pivotal ZUMA study of Yescarta axicabtagene ciloleucel in patients with refractory large Bcell lymphoma With a minimum followup of one…

11

Dec 2017

SCHOTT KAISHA announces path breaking innovation in pharma packaging

SCHOTT KAISHA has introduced stateofthe art technologies and pathbreaking innovations in the pharmaceutical primary packaging space With its advanced operational capabilities SCHOTT KAISHA was the first manufacturer of glass syringes…

11

Dec 2017

Novartis’ Scapho® shows pioneering 4-year data in preventing Ankylosing Spondylitis progression

Novartis announced new longterm Scapho secukinumab data for patients with Ankylosing Spondylitis AS This study is unique as these data show for the first time with any biologic that almost…

EventsRead more...

11-12

Dec 2017

22nd World Cardiology Conference

Conferenceseries Ltd
Holiday Inn Rome Aurelia

12-14

Dec 2017

Gut-Brain Axis Summit 2017

Hanson Wade
Kimpton Sir Francis Drake Hotel

TOP ARTICLES

  • 4

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..

Knowledge Bank

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..

  • Articles

    Nanotherapeutic Intervention in Cancer Disease

    Introduction Cancer is second most prevalent and lethal disease after cardiovascular disorder despite of advances in tumor biology research and chemotherapy The nanotechnology tremendously growing with due advances in nanomedicine and drug delivery system The mantra of nanotherapy in cancer based on right medicine right dose right target right time of exposure patient safety…

  • Techno Trends

    Sanofi and Regeneron’s Cemiplimab Receives FDA "Breakthrough Designation"

    Sanofi and Regeneron announced that Cemiplimab REGN has received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma Cemiplimab is an investigational human monoclonal antibody targeting PD It would be used to treat adults with metastatic cutaneous squamous cell carcinoma CSCC and adults with locally advanced and unresectable CSCC the second deadliest skin cancer after melanoma Preliminary results for…

Editorial Section

  • Strategy

    China Biopharma

    China today according to our recent studies is actively growing its domestic industry not only to support its huge domestic demand for high quality therapeutics but also to develop an export market capability The industry is making progress with substantial…

  • Clinical Trials

    Patient Recruitment

    To address the challenges faced in patient recruitment and retention in clinical trials innovative technologies are being utilised in AsiaPacific as well as other regions to optimise the processes involved From patient matching to improving the consent process technology has…

  • Manufacturing

    Continuous Manufacturing

    The urgent need to dramatically improve efficiency and productivity within the pharmaceutical manufacturing sector is in the state of flux With the US FDAs push for moving the pharmaceutical industry into st century reality of…

  • Expert Talk

    The Asian Healthcare Market

    The Asian market is growing rapidly and along with this expansion comes the issue of drug counterfeiting Bernd offers his insight into the key trends affecting this market and what regulatory authorities are expecting manufacturers…

TOP